Cong Dai (C Dai)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Venous Thromboembolism

Respiratory Syndrome Coronavirus

Patients With Inflammatory Bowel Disease

Top Venues

Inflammatory bowel diseases

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Cong Dai, Yu-Hong Huang
Diagnostic dilemma: sudden onset of multiple skin lesions in a patient with intestinal disease. Gut (2024)
Ying-Jie Li, Jing Li, Cong Dai
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway. mBio (2024)
Dian-Yu Zheng, Yi-Nuo Wang, Yu-Hong Huang, Min Jiang, Yi-Nan Ma, Cong Dai
The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta-analysis. Journal of gastroenterology and hepatology (2024)
Ying-Jie Li, Jing Li, Cong Dai
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway. mBio 15 (8) (2024)
Ying-Jie Li, Jing Li, Cong Dai
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway. mBio 15 (8) (2024)
Cong Dai, Yu-Hong Huang
Rare cause of liver lesion in a patient with ulcerative colitis. Gut (2024)
Ying-Jie Li, Jing Li, Cong Dai
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway. mBio 15 (8) (2024)
Cong Dai, Yu-Hong Huang
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients. Inflammatory bowel diseases (2023)
Cong Dai, Yu-Hong Huang, Min Jiang
Post-COVID-19 irritable bowel syndrome. Gut (2023)
Cong Dai, Yu-Hong Huang, Min Jiang
Post-COVID-19 irritable bowel syndrome. Gut (2023)
Cong Dai, Yu-Hong Huang
Frail Phenotype in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 29 (7) (2023)
Cong Dai, Yu-Hong Huang, Min Jiang
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome. Alimentary pharmacology & therapeutics 58 (1) (2023)
Cong Dai, Yu-Hong Huang
Fatal intestinal disease: a case of recurrent lower gastrointestinal bleeding. Gut (2023)
Cong Dai, Yu-Hong Huang
Venous Thromboembolism following discharge from hospital in patients admitted for Inflammatory Bowel Diseases. Journal of Crohn's & colitis (2022)
Cong Dai, Min Jiang, Yu-Hong Huang
Neutrophil-to-Lymphocyte Ratio for the Diagnosis and Monitoring of Inflammatory Bowel Disease. Digestive diseases and sciences (2022)
Cong Dai, Yu-Hong Huang
The Role of Appendicectomy in Ulcerative Colitis: True or Coincidental Association? Inflammatory bowel diseases 28 (11) (2022)
Cong Dai, Min Jiang, Yu-Hong Huang
Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy. Digestive diseases and sciences 67 (11) (2022)
Wen-Ning Tian, Yu-Hong Huang, Cong Dai
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China. Inflammatory bowel diseases 28 (10) (2022)
Cong Dai, Yu-Hong Huang
Letter: pancreatic involvement in inflammatory bowel disease. Alimentary pharmacology & therapeutics 56 (2) (2022)
Cong Dai, Wei-Xin Liu
Refractory Immune Checkpoint Inhibitor-induced Colitis Improved by Fecal Microbiota Transplantation: A Case Report. Inflammatory bowel diseases (2021)
Cong Dai, Min Jiang, Yu-Hong Huang
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 27 (12) (2021)
Cong Dai, Yu-Hong Huang
Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic". Digestive diseases and sciences (2021)
Cong Dai, Yu-Hong Huang
Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery. Digestive diseases and sciences (2021)
Cong Dai, M Jiang, Y-H Huang
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis. Journal of gastroenterology and hepatology 36 (7) (2021)
Cong Dai, Min Jiang, Yu-Hong Huang
COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China. Digestive diseases and sciences (2021)
Cong Dai, Yu-Hong Huang
A Rare Manifestation of IgG4-Related Disease and Concurrent Idiopathic Hypereosinophilic Syndrome as Extensive Gastrointestinal Lesions: A Case Report. Inflammatory bowel diseases (2021)
Cong Dai, Yu-Hong Huang, Min Jiang
Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab. Inflammatory bowel diseases (2021)
Cong Dai, Min Jiang
Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease. Digestive diseases and sciences 66 (3) (2020)
Cong Dai, Min Jiang, Ming-Jun Sun
Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than IBD. Alimentary pharmacology & therapeutics 50 (7) (2020)
Cong Dai, Min Jiang, Ming-Jun Sun
High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis. Digestive diseases and sciences 64 (5) (2019)
Cong Dai, M Jiang, Q Cao
Proton-Pump Inhibitor use and the risk of Ischaemic Stroke. Journal of internal medicine 283 (3) (2017)
Cong Dai, Q Cao, M Jiang
Letter: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Alimentary pharmacology & therapeutics 46 (10) (2017)